Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neurostimulation to Improve NOWS Outcomes

NCT: NCT05129020 · ACTIVE_NOT_RECRUITING

NCT IDNCT05129020
StatusACTIVE_NOT_RECRUITING
Start Date2022-07-27
Completion2027-01-31

Brief Summary

The objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatment.

Frequently Asked Questions

What is Neurostimulation to Improve NOWS Outcomes?

Neurostimulation to Improve NOWS Outcomes is a clinical trial registered under NCT05129020. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05129020?

The current status of NCT05129020 (Neurostimulation to Improve NOWS Outcomes) is: ACTIVE_NOT_RECRUITING.

When did Neurostimulation to Improve NOWS Outcomes start?

Neurostimulation to Improve NOWS Outcomes started on 2022-07-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑